Status:
COMPLETED
Molehill Mountain Feasibility Study.
Lead Sponsor:
King's College London
Collaborating Sponsors:
South London and Maudsley NHS Foundation Trust
Conditions:
Anxiety
Autism
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Up to half of autistic people experience anxiety symptoms, which can have a significant impact on everyday wellbeing. However, there are currently very few effective, evidence-based interventions to s...
Eligibility Criteria
Inclusion
- Age ≥ 16-years.
- Autism diagnosis.
- Current mild-to-severe anxiety symptom severity, as assessed at screening (and currently in touch with mental health services e.g., referred, on the waitlist).
- Able and willing to provide verbal and written informed consent to take part in the study.
- Access to Molehill Mountain app via SmartPhone or other Smart device.
Exclusion
- Difficulties with reading/ writing to the extent that the app is inaccessible.
- High risk of self-harm that make participation in the study inappropriate for the individual's current level of clinical need (as assessed by clinical team).
- Attended ≥ 6 sessions of individual or group therapy (e.g., cognitive behavioural therapy) in the past 6-months, which would make it impossible to parse out the effects of the app from existing therapy.
- If using psychotropic medication, this medication/ dose must have been stable for a minimum of 8-weeks on entry to the study.
Key Trial Info
Start Date :
September 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 24 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05302167
Start Date
September 6 2022
End Date
October 24 2024
Last Update
October 26 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
King's College London
London, United Kingdom
2
South London and Maudsley NHS Foundation Trust (SLaM)
London, United Kingdom